| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2013/03/01 | 22 : 49 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/27 | 03 : 02 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/15 | 00 : 02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/15 | 00 : 02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/14 | 20 : 08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/14 | 20 : 08 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/12 | 22 : 07 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/12 | 22 : 03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/02/05 | 23 : 01 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/25 | 05 : 51 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/24 | 07 : 26 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/14 | 22 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/14 | 22 : 06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 05 : 33 | Edgar (US Regulatory) | Definitive Materials Filed by Investment Companies. (497) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 05 : 33 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 05 : 33 | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/09 | 03 : 40 | Zacks | Repligen, Pfizer Collaborate - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/08 | 00 : 24 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/08 | 00 : 24 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/05 | 03 : 16 | Zacks | BioMimetic's Pipeline Progresses - Analyst Blog | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07 : 10 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07 : 10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07 : 08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/04 | 07 : 08 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/03 | 23 : 00 | Business Wire | BioMimetic Therapeutics, Inc. Initiates Enrollment in Augment™ Chronic Tendinopathy Clinical Trial | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2013/01/03 | 17 : 14 | Zacks | Zacks #1 Rank Additions for Thursday - Tale of the Tape | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20 : 03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20 : 03 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20 : 03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |
| 2012/12/26 | 20 : 03 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:BMTI | Biomimetic Therapeutics, Inc. (MM) |